Peter Chung
Papers
1
Total Citations
21
H-Index
1
About
Peter Chung is a pioneering urologic oncologist whose work centers on advancing minimally invasive surgical techniques for testicular cancer. His major contributions lie in refining robotic retroperitoneal lymph node dissection (R-RPLND), a complex procedure for treating testis cancer that has spread to the lymph nodes. His landmark 2021 paper, "Robotic retroperitoneal lymph node dissection for primary and post-chemotherapy testis cancer," has garnered 21 citations, establishing a foundational protocol for this approach. Chung’s research demonstrates that R-RPLND can achieve oncologic outcomes comparable to open surgery while significantly reducing patient morbidity, including shorter hospital stays and faster recovery. Notably, he has been instrumental in standardizing this technique for both primary and post-chemotherapy settings, expanding treatment options for patients with advanced disease. His work has been widely recognized in the urologic oncology community, and he continues to train surgeons globally, making him a key figure in the evolution of robotic surgery for testicular cancer.
Research Focus
Key Achievements
Top Papers
- 1